Table of Content

Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview
Polymerase Chain Reaction Technology
Point of Care PCR Systems and Assays

Chapter 3 Market Dynamics
Market Dynamics Snapshot
Market Drivers
Market Opportunities
Market Restraints
Market Challenges

Chapter 4 Emerging Technologies and Developments
Overview
Instrument-Free PCR Tests
Five-Minute Point-of-Care Testing
Smartphone Enabled PCR System
Patents
Selected Patents

Chapter 5 Global Market for PCR POC Diagnostics
Segmentation Breakdown
Market Breakdown by Product Type
Market Breakdown by Analyte
PCR POC Analyzers by Analyte
PCR POC Consumables by Analyte
Market Breakdown by Application
Infectious Diseases
STIs
Geographic Breakdown
Market Breakdown by Region
North America
Latin America
Europe
Asia-Pacific
Rest of the World

Chapter 6 Competitive Intelligence
Industry Scenario
Company Shares
Competitive Landscape Among Companies
Competitive Landscape in POC PCR Analyzers
Competitive Landscape in POC PCR Consumables

Chapter 7 Sustainability in the Market for Polymerase Chain Reaction for Point of Care Diagnostics: An ESG Perspective
Introduction to ESG
Sustainability in Polymerase Chain Reaction for Point-of-Care Diagnostic Industry: An ESG Perspective
Key ESG Issues
ESG Performance Analysis

Chapter 8 Appendix
Research Methodology
Acronyms
References
Company Profiles
ABBOTT
CREDO DIAGNOSTICS BIOMEDICAL PTE. LTD.
DANAHER CORP.
F. HOFFMANN-LA ROCHE LTD.
QIAGEN
QUANTUMDX GROUP LTD.
THERMO FISHER SCIENTIFIC INC.
VISBY MEDICAL INC.



List of Figures


Summary Figure A : Global Market for Polymerase Chain Reaction for Point-of-Care Diagnostics, by Product Type, 2021–2029
Summary Figure B : Global Market Shares of Polymerase Chain Reaction for Point-of-Care Diagnostics, by Product Type, 2023
Figure 1 : Polymerase Chain Reaction for Point of Care Diagnostics: Market Dynamics
Figure 2 : Emerging Trends and Technologies in PCR for POC Diagnostics
Figure 3 : Global Market Shares of PCR POC Diagnostics, by Company, 2023
Figure 4 : Global Market Shares of POC PCR Analyzers, by Company, 2023
Figure 5 : Global Market Shares of POC PCR Consumables, by Company, 2023
Figure 6 : ESG Pillars
Figure 7 : Advantages of ESG for Companies
Figure 8 : Share of ESG Penetration in Polymerase Chain Reaction POC Diagnostics Market, 2023
Figure 9 : Abbott: Revenue Share, by Business Unit, 2023
Figure 10 : Abbott: Revenue Share, by Country/Region, 2023
Figure 11 : Danaher Corp.: Revenue Share, by Business Unit, FY 2023
Figure 12 : Danaher Corp.: Revenue Share, by Country/Region, FY 2023
Figure 13 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 14 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 15 : QIAGEN: Revenue Share, by Business Unit, FY 2023
Figure 16 : QIAGEN: Revenue Share, by Country/Region, FY 2023
Figure 17 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
Figure 18 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023

List of Tables


Summary Table : Global Market for Polymerase Chain Reaction for Point-of-Care Diagnostics, by Product Type, Through 2029
Table 1 : Global HIV Infections, 2022
Table 2 : People Living with HIV, by Region, 2022
Table 3 : Global Incidence of All Cancers, by Region, 2022–2050
Table 4 : Global Incidence of Leukemia, by Region, 2022–2050
Table 5 : Global Incidence of Hodgkin Lymphoma, by Region, 2022–2050
Table 6 : Global Incidence of Non-Hodgkin Lymphoma, by Region, 2022–2050
Table 7 : Global Incidence of Multiple Myeloma, by Region, 2022–2050
Table 8 : Selected Patents on PCR POC Technology, 2015–Present
Table 9 : Global Market for PCR POC Diagnostics, Through 2029
Table 10 : Global Market for PCR POC Diagnostics, by Product Type, Through 2029
Table 11 : Global Market for PCR POC Analyzers, by Analyte, Through 2029
Table 12 : Global Market for Single Analyte PCR POC Analyzers, by Region, Through 2029
Table 13 : Global Market for Multi-Analyte PCR POC Analyzers , by Region, Through 2029
Table 14 : Global Market for PCR POC Consumables, by Analyte, Through 2029
Table 15 : Global Market for Single Analyte PCR POC Consumables, by Region, Through 2029
Table 16 : Global Market for Multi-Analyte PCR POC Consumables, by Region, Through 2029
Table 17 : Global Market for PCR for POC Diagnostics, by Application, Through 2029
Table 18 : Global Market for PCR POC Diagnostics in Infectious Diseases, Through 2029
Table 19 : Global Market for PCR POC Diagnostics in Infectious Diseases, by Region, Through 2029
Table 20 : North American Market for PCR POC Diagnostics in Infectious Diseases, Through 2029
Table 21 : North American Market for PCR POC Diagnostics in Infectious Diseases, by Country, Through 2029
Table 22 : Latin American Market for PCR POC Diagnostics in Infectious Diseases, Through 2029
Table 23 : Latin American Market for PCR POC Diagnostics in Infectious Diseases, by Country, Through 2029
Table 24 : European Market for PCR POC Diagnostics in Infectious Diseases, Through 2029
Table 25 : European Market for PCR POC Diagnostics in Infectious Diseases, by Country, Through 2029
Table 26 : Asia-Pacific Market for PCR POC Diagnostics in Infectious Diseases, Through 2029
Table 27 : Asia-Pacific Market for PCR POC Diagnostics in Infectious Diseases, by Country, Through 2029
Table 28 : RoW Market for PCR POC Diagnostics in Infectious Diseases, Through 2029
Table 29 : Global Market for PCR POC Diagnostics in STIs, Through 2029
Table 30 : Global Market for PCR POC Diagnostics in STIs, by Region, Through 2029
Table 31 : North American Market for PCR POC Diagnostics in STIs, Through 2029
Table 32 : North American Market for PCR POC Diagnostics in STIs, by Country, Through 2029
Table 33 : Latin American Market for PCR POC Diagnostics in STIs, Through 2029
Table 34 : Latin American Market for PCR POC Diagnostics in STIs, by Country, Through 2029
Table 35 : European Market for PCR POC Diagnostics in STIs, Through 2029
Table 36 : European Market for PCR POC Diagnostics in STIs, by Country, Through 2029
Table 37 : Asia-Pacific Market for PCR POC Diagnostics in STIs, Through 2029
Table 38 : Asia-Pacific Market for PCR POC Diagnostics in STIs, by Country, Through 2029
Table 39 : RoW Market for PCR POC Diagnostics in STIs, Through 2029
Table 40 : Global Market for PCR for POC Diagnostics, by Region, Through 2029
Table 41 : North American Market for PCR POC Diagnostics, by Product Type, Through 2029
Table 42 : North American Market for PCR POC Diagnostics, by Country, Through 2029
Table 43 : Latin American Market for PCR POC Diagnostics, by Product Type, Through 2029
Table 44 : Latin American Market for PCR POC Diagnostics, by Country, Through 2029
Table 45 : European Market for PCR POC Diagnostics, by Product Type, Through 2029
Table 46 : European Market for PCR POC Diagnostics, by Country, Through 2029
Table 47 : Asia-Pacific Market for PCR POC Diagnostics, by Product Type, Through 2029
Table 48 : Asia-Pacific Market for PCR POC Diagnostics, by Country, Through 2029
Table 49 : RoW Market for PCR POC Diagnostics, by Product Type, Through 2029
Table 50 : ESG: Environmental Overview
Table 51 : ESG: Social Overview
Table 52 : ESG: Governance Overview
Table 53 : ESG Rankings for Polymerase Chain Reaction Point-of-Care Diagnostics Companies, 2023*
Table 54 : Acronyms Used in This Report
Table 55 : Abbott: Company Snapshot
Table 56 : Abbott: Financial Performance, 2022 and 2023
Table 57 : Abbott: Product Portfolio
Table 58 : Abbott: News/Key Developments, 2022
Table 59 : Credo Diagnostics Biomedical Pte. Ltd.: Company Snapshot
Table 60 : Credo Diagnostics Biomedical Pte. Ltd.: Product Portfolio
Table 61 : Credo Diagnostics Biomedical Pte. Ltd.: News/Key Developments, 2022
Table 62 : Danaher Corp.: Company Snapshot
Table 63 : Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 64 : Danaher Corp.: Product Portfolio
Table 65 : Danaher Corp.: News/Key Developments, 2023 and 2024
Table 66 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 67 : F. Hoffmann-La Roche Ltd.: Financial Performance, 2022 and 2023
Table 68 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 69 : QIAGEN: Company Snapshot
Table 70 : QIAGEN: Financial Performance, FY 2022 and 2023
Table 71 : QIAGEN: Product Portfolio
Table 72 : QIAGEN: News/Key Developments, 2022
Table 73 : Quantumdx Group Ltd.: Company Snapshot
Table 74 : Quantumdx Group Ltd.: Product Portfolio
Table 75 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 76 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 77 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 78 : Thermo Fisher Scientific Inc.: News/Key Developments, 2021
Table 79 : Visby Medical Inc.: Company Snapshot
Table 80 : Visby Medical Inc.: Product Portfolio
Table 81 : Visby Medical Inc.: News/Key Developments, 2023